Skip to content

Two New TAG Publications

  • Chad Cipiti

Research Funding Gaps Revealed Treatment Action Group has published two new reports on the crisis in national and international funding for scientific research on AIDS, tuberculosis (TB), and viral hepatitis. TB and hepatitis are diseases that affect hundreds of millions…

Read more

State AIDS Drug Assistance Program (ADAP) Hepatitis Coverage

  • Chad Cipiti

Hepatitis C Treatment, Psychiatric Medications (SSRIs), Growth Factors, Hepatitis Vaccines (March 2009) Hepatitis C virus (HCV) is a common and serious comorbidity among HIVpositive people in the United States; up to 30%—approximately 332,000— are living with HCV. Hepatitis C can…

Read more

A Long-Term Survivor: The Pioneering MACS Cohort

  • Chad Cipiti

By Gregg Gonsalves Adapted from remarks given on May 12, 2009, at the Carnegie Institution for Science in Washington, D.C., at a celebration for the 25th anniversary of the Multicenter AIDS Cohort Study (MACS), an ongoing prospective study of the…

Read more

The HIV Entry Ban: What’s Next?

  • Chad Cipiti

A Talk with Nancy Ordover By Bob Huff Nancy Ordover, PhD, has served on the International Task Team on HIV-Related Travel Restrictions, convened by UNAIDS and concerned with issues relating to the human rights, public health, and economic impact of…

Read more

The Virtual AIDS Conference: CROI Webcasts Reviewed

  • Chad Cipiti

Webcasts make CROI the most accessible AIDS conference of the year. By Bob Huff The Conference on Retroviruses and Opportunistic Infections (CROI) is the most important scientific meeting on HIV and AIDS during the year. Although attendance at CROI is…

Read more

New Hepatitis C Epidemic Outbreaks in HIV-Positive Gay Men

  • Chad Cipiti

  Outbreaks of sexually transmitted hepatitis C infection have been reported among HIV-positive gay men. Early diagnosis and treatment can prevent serious liver disease, but too few doctors notice the warning signs. BY Tracy Swan A new epidemic of hepatitis…

Read more

TAG to NIAID: Recommendations to Stimulate Research on HIV Persistence

  • Chad Cipiti

  Treatment Action Group’s response to the National Institute of Immunology and Infectious Diseases (NIAID) request for comments on the development of a research funding opportunity on HIV latency and persistence. Treatment Action Group (TAG) strongly supports reinvigorating the research…

Read more
Back To Top